How genes shape the body's daily clock

Genetics of human circadian rhythms: using sequencing, novel phenotyping methods, and functional assays to move towards a deeper understanding of circadian mechanisms

NIH-funded research Brigham and Women's Hospital · NIH-11141177

This project looks at people's genes and daily sleep/activity patterns to find genetic links to body-clock differences that can affect sleep, mood, cancer risk, and heart/metabolic health.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionBrigham and Women's Hospital NIH-funded
Lab location1 site (Boston, United States)
Project IDNIH-11141177 on NIH RePORTER

What this research studies

You would see researchers use large biobanks to find people with very early or very late sleep patterns and sequence their DNA to look for rare genetic changes. They are developing easy, scalable ways to measure daily rhythms using wearables, smartphone data, and short home tests so many people can be included. When candidate genes are found, lab-based cellular tests will be used to see how those changes affect the internal cellular clock. The team aims to turn these findings into better timing-based prevention or treatment ideas for sleep and related health problems.

Who could benefit from this research

Good fit: Ideal candidates are people with very early or very late sleep schedules, clear circadian timing disorders, or those willing to share detailed activity/sleep data and genetic samples.

Not a fit: People without sleep or circadian-related issues, or those seeking an immediate clinical therapy, are unlikely to get direct benefit from this research.

Why it matters

Potential benefit: If successful, this work could lead to new ways to prevent or treat sleep-timing problems and related conditions by targeting the body's clock or timing treatments to each person's biology.

How similar studies have performed: Previous genetic studies have linked some genes to sleep timing, but combining biobank-driven rare variant sequencing with large-scale phenotyping and cellular functional follow-up is a newer and promising approach.

Where this research is happening

Boston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions CancersCardiometabolic DiseaseCardiometabolic Disorder
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.